Skip to main content

Table 1 Patient characteristics by occurrence of symptomatic cerebral vasospasm

From: Can admission lipoprotein-associated phospholipase A2 predict the symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage?

CharacteristicsTotal (n = 128)SCV (n = 12)No SCV (n = 116)P value
Demographics
 Age, year53.44 ± 10.5155.00 ± 9.9553.28 ± 10.590.590
 Gender, female70 (54.69%)7 (58.33%)63 (54.31%)0.790
Admission clinical grade
 WFNS grade   0.007
 Grade I56 (43.75%)1 (8.33%)55 (47.41%) 
 Grade II6 (4.69%)1 (8.33%)5 (4.31%) 
 Grade III14 (10.94%)2 (16.67%)12 (10.34%) 
 Grade IV30 (23.44%)3 (25.00%)27 (23.28%) 
 Grade V22 (17.19%)5 (41.67%)17 (14.66%) 
Admission blood pressure
 SAP, mmHg146.36 ± 23.97140.08 ± 25.50147.01 ± 23.830.343
 DAP, mmHg83.88 ± 11.7081.42 ± 9.3184.14 ± 11.920.445
 MAP, mmHg104.71 ± 14.34100.97 ± 13.99105.09 ± 14.380.345
Admission CT scan grade
 Modified Fisher grade2 (2–3)2 (2–3)4 (3–4)< 0.001
Medical history
 Hypertension57 (44.53%)7 (58.33%)50 (43.10%)0.312
 Diabetes mellitus16 (12.50%)3 (25.00%)13 (11.21%)0.174
 Cardiovascular disease19 (14.84%)3 (25.00%)16 (13.79%)0.385
Smoking history35 (27.34%)4 (33.33%)31 (26.72%)0.735
Aneurysm characteristics
 Aneurysm size, mm7.25 ± 4.248.75 ± 6.227.09 ± 3.990.197
 Multiple aneurysms35 (27.34%)3 (25.00%)32 (27.59%)1.000
 Anterior circulation94 (73.44%)9 (75.00%)85 (73.28%)1.000
 Clipping109 (85.16%)11 (91.67%)98 (84.48%)1.000
Laboratory
 Lp-PLA2, μg/L182.09 ± 60.09224.47 ± 76.14177.70 ± 56.790.010
Medical complications
 Pneumonia51 (39.84%)8 (66.67%)43 (37.07%)0.063
 Intracranial infection11 (8.59%)1 (8.33%)10 (8.62%)1.000
 Sepsis5 (3.91%)1 (8.33%)4 (3.45%)0.394
 Hydrocephalus18 (14.06%)2 (16.67%)16 (13.79%)0.677
  1. Values are n (%), mean ± SD, median (25–75%)
  2. SCV symptomatic cerebral vasospasm, SAP systolic arterial pressure, DAP diastolic arterial pressure, MAP mean arterial pressure, Lp-PLA2 lipoprotein-associated phospholipase A2